An interventional study of Fatty Acids Compounds (F.A.G.) Mouthwash and Stannous Fluoride (SF) Mouthwash in Gingivitis and Gingival Diseases, sponsored by University of L'Aquila. Completed at 1 site in Italy. Open to participants aged 18 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-09-26.
Sponsored by University of L'Aquila · Not applicable, Interventional, and Treatment
Comparative study on the efficacy of two mouthwashes Containing Fatty Acids Compounds (F.A.G.) or Stannous Fluoride in the reduction of plaque score in individuals with spontaneous gengivitis
590 studies on the registry are indexed under Gingivitis; 104 are open to participants now.
This study's enrollment of 34 is below the median of 64 across 478 interventional studies indexed under Gingivitis.
Browse Gingivitis studies →University of L'Aquila is the lead sponsor of 45 studies on the registry; 9 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Individuals taking FAG mouthwash
Drug: Fatty Acids Compounds (F.A.G.) Mouthwash
Individuals taking SF mouthwash
Drug: Stannous Fluoride (SF) Mouthwash
Fatty Acids Compounds (F.A.G.) Mouthwash
Stannous Fluoride (SF) Mouthwash
Change in plaque score
Visual quantification of dental plaque amount on teeth buccal surfaces (wisdom teeth excluded). 0% = no visible plaque on teeth surfaces 100% = plaque visible on all teeth surfaces
Time frame: Baseline; 2 weeks
Bleeding on Probing
Quantifying gingival bleeding after gentle gum manipulation assessed on 6 points per tooth (exluded wisdom teeth). 0% = No bleeding on all assessed points 100% = Bleeding on all assessed points
Time frame: Baseline; 2 weeks
Plan to share: Undecided
No publications or documents are linked to this record.
This study is completed, as verified in Sep 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of L'Aquila